Alzheimer's disease (AD) is a memory-related disease that occurs in the human brain where neurons become degenerative. It is an evolved form of dementia that deteriorates over time. Machine learning, an extended version of deep learning, has appeared as an optimistic strategy for AD detection. Regardless, the existing AD detection approaches have yet to acquire the expected accuracy, mainly due to unreasonable data for training and testing. In this paper, we present the Federated Deep Convolutional Neural Network Alzheimer Detection Schemes (FDCNN-AS), specifically designed for varying age groups. FDCNN-AS is an efficient framework that contains architecture, algorithm flow, and implementation. It manages AD data from various laboratories and processes it in additional clinics. Our method mixes training data models from different types of data such as positron emission tomography, summed tomography, magnetic resonance imaging, blood tests, and questionnaires about synaptic degeneration. Further, we look at some restrictions that have yet to be addressed in AD detection. These include seeing AD at different ages, extrapolating the severity of brain damage, comparing treatment and recovery rates, and finding benign and malignant ranges in AD data that has been collected. To ensure secure and privacy-preserving learning, we execute FDCNN-AS within a federated learning environment that concerns considerable laboratories and clinics. Within this setup, we operate the generic deep convolutional neural network. The experimental results indicate that FDCNN-AS performs optimally, reaching a remarkable 99% accuracy in detecting dementia Alzheimer's in the human brain.
Read full abstract